Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avalo Therapeutics (AVTX) Share-based Compensation (2016 - 2025)

Avalo Therapeutics' Share-based Compensation history spans 12 years, with the latest figure at $4.5 million for Q4 2025.

  • For Q4 2025, Share-based Compensation rose 55.23% year-over-year to $4.5 million; the TTM value through Dec 2025 reached $13.6 million, up 132.76%, while the annual FY2025 figure was $13.6 million, 132.76% up from the prior year.
  • Share-based Compensation reached $4.5 million in Q4 2025 per AVTX's latest filing, up from $3.2 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $5.3 million in Q1 2022 to a low of $471000.0 in Q2 2024.
  • Average Share-based Compensation over 5 years is $1.9 million, with a median of $1.6 million recorded in 2021.
  • Peak YoY movement for Share-based Compensation: plummeted 83.9% in 2023, then skyrocketed 477.07% in 2025.
  • A 5-year view of Share-based Compensation shows it stood at $1.9 million in 2021, then tumbled by 55.44% to $843000.0 in 2022, then dropped by 7.95% to $776000.0 in 2023, then surged by 274.23% to $2.9 million in 2024, then skyrocketed by 55.23% to $4.5 million in 2025.
  • Per Business Quant, the three most recent readings for AVTX's Share-based Compensation are $4.5 million (Q4 2025), $3.2 million (Q3 2025), and $2.7 million (Q2 2025).